This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Coudry RA , Meireles SI , Stoyanova R , Cooper HS , Carpino A , Wang XQ , Engstrom PF , Clapper ML
Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue
Journal of Molecular Diagnostics. 2007 Feb;9(1) :70-79
AbstractThe establishment of a reliable method for using RNA from formalin-fixed, paraffin-embedded (FFPE) tissue would provide an opportunity to obtain novel gene expression data from the vast amounts of archived tissue. A custom-designed 22,000 oligonucleotide array was used in the present study to compare the gene expression profile of colonic epithelial cells isolated by laser capture microdissection from FFPE-archived samples with that of the same cell population from matched frozen samples, the preferred source of RNA. Total RNA was extracted from FFPE tissues, amplified, and labeled using the Paradise Reagent System. The quality of the input RNA was assessed by the Bioanalyzer profile, reverse transcriptase-polymerase chain reaction, and agarose gel electrophoresis. The results demonstrate that it is possible to obtain reliable microarray data from FFPE samples using RNA acquired by laser capture microdissection. The concordance between matched FFPE and frozen samples was evaluated and expressed as a Pearson's correlation coefficient, with values ranging from 0.80 to 0.97. The presence of ribosomal RNA peaks in FFPE-derived RNA was reflected by a high correlation with paired frozen samples. A set of practical recommendations for evaluating the RNA integrity and quality in FFPE samples is reported.
NotesISI Document Delivery No.: 131VF Times Cited: 0 Cited Reference Count: 16 Cited References: BIBIKOVA M, 2004, AM J PATHOL, V165, P1799 CRONIN M, 2004, AM J PATHOL, V164, P35 ELKAHLOUN AG, 2002, CANCER BIOL THER, V1, P354 GODFREY TE, 2000, J MOL DIAGN, V2, P84 KARSTEN SL, 2002, NUCLEIC ACIDS RES, V30 LECHPAMMER M, 2004, EXPERT REV MOL DIAGN, V4, P429 LEHMANN U, 2001, METHODS, V25, P409 LIPSHUTZ RJ, 1999, NAT GENET S, V21, P20 MA XJ, 2004, CANCER CELL, V5, P607 MASUDA N, 1999, NUCLEIC ACIDS RES, V27, P4436 RAMASWAMY S, 2004, NEW ENGL J MED, V350, P1814 RESNICK MB, 2006, GUT, V55, P1717 SOGUERO C, 1999, LAB INVEST, V79, P365 SPECHT K, 2001, AM J PATHOL, V158, P419 VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663 WANG E, 2000, NAT BIOTECHNOL, V18, P457